Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Telomir Pharmaceuticals Inc (TELO)

Telomir Pharmaceuticals Inc (TELO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 153,972
  • Shares Outstanding, K 29,610
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,070 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 340.98

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.20 +62.60%
on 11/19/24
7.08 -26.54%
on 12/06/24
+1.22 (+30.65%)
since 11/13/24
3-Month
3.20 +62.60%
on 11/19/24
8.40 -38.10%
on 09/20/24
-0.87 (-14.33%)
since 09/13/24

Most Recent Stories

More News
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price

Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals Achieves Breakthrough in Type 2 Diabetes Treatment with Novel Age-Reversal Drug

Telomir Pharmaceuticals has made a significant breakthrough in diabetes research, demonstrating that their novel compound, Telomir-1, can reverse key parameters of Type 2 diabetes by addressi

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1

Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels...

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals' Breakthrough Study Reveals Major Age-Reversal Results in Advanced Preclinical Testing

Telomir Pharmaceuticals has made a significant breakthrough in longevity science with Telomir-1, a compound that demonstrates remarkable age-reversal effects, including extended lifespan, imp

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1

MIAMI, FL / ACCESSWIRE / November 21, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking preclinical...

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals' Age Reversal Pill Shows Promise in Canine Study

A recent ABC exclusive highlighted Telomir Pharmaceuticals' "age reversal" pill, showing remarkable results in two senior dogs. The company's innovative approach to longevity science has spar

TELO : 5.20 (+2.16%)
Discover the Future of Youthfulness with Telomir Pharmaceuticals' Breakthrough Technology

Telomir Pharmaceuticals is a pharmaceutical company whose main focus is on the development and commercialization of Telomir-1.

TELO : 5.20 (+2.16%)

Business Summary

Telomir Pharmaceuticals Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Telomir Pharmaceuticals Inc. is based in BALTIMORE....

See More

Key Turning Points

3rd Resistance Point 6.58
2nd Resistance Point 5.97
1st Resistance Point 5.58
Last Price 5.20
1st Support Level 4.58
2nd Support Level 3.97
3rd Support Level 3.58

See More

52-Week High 20.72
Fibonacci 61.8% 13.99
Fibonacci 50% 11.91
Fibonacci 38.2% 9.84
Last Price 5.20
52-Week Low 3.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar